Chenopodium quinoa-based functional formulation

Intervention

1 paper2 findings

  • 1 lab
  • Human trial1

Associations

2

CD33+CX3CR1+CD44+TLR4+ monocytes

mixedin humans1

1 study
  1. Chenopodium quinoa-based functional formulation is associated with CD33+CX3CR1+CD44+TLR4+ monocytes in humans.

    “The FF affects the proportion of CD33+CX3CR1+CD44+TLR4+ monocytes and innate lymphoid cells (ILCs) and the PLs profile.”

    Human trial12 days

    Healthy Improvement of Metabolic Biomarkers During an Immunonutritional Intervention: A Crossover Controlled Trial

    Molecular nutrition & food research1 Mar 2026

More on CD33+CX3CR1+CD44+TLR4+ monocytes

Insulin

mixedin humans1

1 study
  1. Chenopodium quinoa-based functional formulation is associated with insulin in humans.

    “Interaction plots revealed significant effects depending on the product consumed and the intervention period for insulin, triglycerides, APOA, and monocytes' phenotype.”

    Human trial12 days

    Healthy Improvement of Metabolic Biomarkers During an Immunonutritional Intervention: A Crossover Controlled Trial

    Molecular nutrition & food research1 Mar 2026

More on Insulin

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months